ArticleRespiratory research2025

Exploring a mutation-based signature to predict the benefits of immune checkpoint inhibitors in oncogene-addicted subsets of non-small cell lung cancer: a retrospective study.

Jing Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.